Chinese patent medicine as a complementary and alternative therapy for type 2 diabetes mellitus: A scoping review
Objective: This scoping review aims to document Chinese Patent Medicines (CPMs) for Type 2 Diabetes Mellitus, explore whether CPMs can improve patients’ health outcomes, and set priorities in addressing research gaps in this area. Methods: Following the framework of PRISMA-SCr, we proposed the resea...
Main Authors: | Hai-Zhu Zheng, Tian-Ying Chang, Bo Peng, Shi-Qi Ma, Zhen Zhong, Jia-Zhen Cao, Lin Yao, Meng-Yuan Li, Hong-Feng Wang, Xing Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Complementary Therapies in Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0965229924000025 |
Similar Items
-
Patenting human genes: Chinese academic articles’ portrayal of gene patents
by: Li Du
Published: (2018-04-01) -
Chinese patent medicine - New treatment for tic disorder
by: Junze Geng, et al.
Published: (2022-09-01) -
The reporting checklist for Chinese patent medicine guidelines: RIGHT for CPM
by: Xuanlin Li, et al.
Published: (2024-01-01) -
Natural Products as Outstanding Alternatives in Diabetes Mellitus: A Patent Review
by: Ingrid Andrea Rodríguez, et al.
Published: (2022-12-01) -
Clinical Progress on Management of Pneumonia Due to COVID-19 With Chinese Traditional Patent Medicines
by: Ying Wu, et al.
Published: (2021-09-01)